EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigenetic and ncRNA Regulation of CBX2 in Liver Hepatocellular Carcinoma: A Comprehensive Multi-Omics Analysis for Understanding Biological Significance

Kyu-Shik Lee iD, Jong-Heon Kim, Jongwan Kim iD

Medicina · 28.04.2026 · 62 (5) · 842

DOI: 10.3390/medicina62050842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, online erschienen am 28.04.2026. Verfasst von Kyu-Shik Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Dongguk University, Gyeongju 38066, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Polycomb Repressive Complex 1, RNA, Untranslated. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dongguk University WISE, Dongguk University College of Medicine Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Chromobox protein homolog 2 (CBX2), a member of the polycomb group of proteins that plays a role in chromatin remodeling, has been associated with multiple types of cancer. However, its characterization in liver hepatocellular carcinoma (LIHC) has not been fully elucidated. This study aims to systemically evaluate the expression, prognostic value, epigenetic regulation, and ncRNAs of CBX2 in LIHC. Materials and Methods: We performed a comprehensive in silico analysis to assess CBX2 expression at mRNA and protein levels, correlate its expression with clinical characteristics and prognosis, and explore DNA methylation and ncRNA-mediated regulatory networks. Multiple public databases (TIMER2.0, UALCAN, Human Protein Atlas, KM Plotter, MethSurv, miRNet, and ENCORI) were utilized to conduct expression, survival analysis, and construct a network encompassing miRNAs, lncRNAs, and pseudogenes.

Results

CBX2 expression was found to be elevated in LIHC at both the mRNA and protein expression level. Increased CBX2 expression was closely linked with unfavorable clinical outcome. Methylation analysis indicated that various CpG sites, exhibiting both hypermethylation and hypomethylation patterns, were correlated with CBX2 expression and patient prognosis. Among the identified ncRNAs, hsa-miR-101-3p tended to be downregulated, whereas hsa-miR-222-3p was significantly upregulated in LIHC, and both were associated with CBX2 expression and clinical outcomes. The constructed ncRNA interaction network suggested potential associations among miRNA, lncRNAs, and pseudogenes that may be linked to tumor progression.

Conclusions

Our results suggest that CBX2 was overexpressed in LIHC and may be associated with epigenetic alterations and ncRNA-related regulatory interactions. Its expression shows a relationship with clinical prognosis, suggesting that CBX2 could serve as a candidate biomarker. The proposed CBX2-associated ncRNA network represents a potential framework for further investigation, although additional experimental validation is required to confirm its biological and clinical relevance. Consequently, our findings suggest that CBX2 may serve as a potential prognostic biomarker and therapeutic target in LIHC, potentially influenced by specific epigenetic and post-transcriptional mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPolycomb Repressive Complex 1RNA, UntranslatedEpigenesis, GeneticHumansDNA MethylationMultiomicsPrognosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CBX2DNA methylationLIHCncRNAsprognostic biomarker

Substanzen

CBX2 protein, humanPolycomb Repressive Complex 1RNA, Untranslated

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.
  • Brain Science & Engineering Institute, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea.
  • Department of Anatomy, College of Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.

ORCID-Profile: Kyu-Shik Lee, Jongwan Kim

Förderung

  • Dongguk University WISE
  • Dongguk University College of Medicine Research Fund

Zitieren

APA

Lee, K. S., Kim, J. H., & Kim, J. (2026). Epigenetic and ncRNA Regulation of CBX2 in Liver Hepatocellular Carcinoma: A Comprehensive Multi-Omics Analysis for Understanding Biological Significance. Medicina, 62(5), 842. https://doi.org/10.3390/medicina62050842

Vancouver

Lee KS, Kim JH, Kim J. Epigenetic and ncRNA Regulation of CBX2 in Liver Hepatocellular Carcinoma: A Comprehensive Multi-Omics Analysis for Understanding Biological Significance. Medicina. 2026;62(5):842. doi:10.3390/medicina62050842

BibTeX
@article{Lee2026,
  author = {Lee, Kyu-Shik and Kim, Jong-Heon and Kim, Jongwan},
  title = {Epigenetic and ncRNA Regulation of CBX2 in Liver Hepatocellular Carcinoma: A Comprehensive Multi-Omics Analysis for Understanding Biological Significance},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {5},
  pages = {842},
  doi = {10.3390/medicina62050842}
}
Kostenlos starten →